2,5-disubstituted piperidine orexin receptor antagonists

Details for Australian Patent Application No. 2009307913 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Breslin, Michael J.; Coleman, Paul J.; Cox, Christopher D.; Schreier, John D.; Whitman, David B.

Agent Spruson & Ferguson

Pub. Number AU-A-2009307913

PCT Pub. Number WO2010/048010

Priority 61/196,849 21.10.08 US

Filing date 15 October 2009

Wipo publication date 29 April 2010

International Classifications

C07D 413/00 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/048010 Priority application(s): WO2010/048010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009307915-2,5-disubstituted piperidine orexin receptor antagonists

2009307901-Method for treating pulmonary arterial hypertension